A Review of the Neurosurgical Management of Brain Metastases During Pregnancy.
Phileas J ProskynitopoulosFred C LamSunjay SharmaBrett C YoungYosef LavivEkkehard M KasperPublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2020)
Management of PASBT remains a challenging issue. Maternal and fetal risks associated with surgical resection and teratogenicity due to adjuvant therapy should be discussed in the context of a multidisciplinary team. Timing of surgery and the use of systemic chemoradiation depends on the gestational age (GA) of the fetus, extent, and control of the mother's primary and metastatic disease. Guidelines need to be established to help neuro-oncology teams safely and effectively manage this group of patients.
Keyphrases
- gestational age
- brain metastases
- birth weight
- small cell lung cancer
- palliative care
- end stage renal disease
- ejection fraction
- newly diagnosed
- squamous cell carcinoma
- preterm birth
- minimally invasive
- pet ct
- prognostic factors
- rectal cancer
- quality improvement
- coronary artery disease
- pregnant women
- atrial fibrillation
- drug induced